Overview
What is it?
Locally delivered antibiotics are sustained-release antimicrobial formulations placed directly into periodontal pockets. Common products include Arestin (minocycline microspheres), Atridox (doxycycline gel), and PerioChip (chlorhexidine chip).
How does it work?
These formulations release high concentrations of antibiotic directly into the periodontal pocket over several days to weeks, achieving local drug levels far exceeding those possible with systemic delivery while minimizing systemic side effects.
When is it commonly used?
Used as an adjunct to SRP in sites with persistent deep pockets, localized aggressive periodontitis, or sites that have not responded adequately to initial therapy. Not for all sites — selected for specific persistent pockets.
Mechanism of Action
Local antibiotics achieve sustained drug concentrations in gingival crevicular fluid (GCF) that exceed minimum inhibitory concentrations (MIC) for periodontal pathogens. Minocycline and doxycycline inhibit bacterial protein synthesis by binding the 30S ribosomal subunit. Chlorhexidine disrupts bacterial cell membranes. The sustained-release delivery maintains therapeutic levels for 7–21 days depending on the product.
Organisms Studied
| Organism | Abbr. | Research Finding |
|---|---|---|
| Porphyromonas gingivalis | Pg | Reduced by minocycline and doxycycline local delivery as adjunct to SRP. |
| Tannerella forsythia | Tf | Reduction demonstrated in clinical trials of locally delivered antibiotics. |
| Treponema denticola | Td | Part of red complex; reduced alongside Pg and Tf. |
| Aggregatibacter actinomycetemcomitans | Aa | Minocycline microspheres show reduction in Aa-positive sites, though complete elimination is difficult. |
Evidence Summary
Benefits
- High local drug concentration with minimal systemic exposure
- Modest but statistically significant improvements in probing depth and clinical attachment
- Easy to apply chairside
- Useful for localized persistent sites
Limitations
- Additional cost per site
- Benefits are modest and may not be clinically significant at individual sites
- Not all patients or sites benefit equally
- Risk of antibiotic resistance with repeated use
Quality of Evidence
Moderate evidence from multiple RCTs and systematic reviews supporting modest adjunctive benefit over SRP alone.
Key Clinical Takeaways
- 1Best used selectively for persistent localized pockets
- 2Benefit is adjunctive, not standalone
- 3Consider antimicrobial stewardship when using repeatedly
Evidence Meter
Several clinical studies support use, but evidence has some limitations in design or consistency.
Frequently Asked Questions
References
Local antimicrobials in periodontal therapy: A systematic review and meta-analysis
Hanes PJ, Purvis JP (2003)
DOI: 10.1902/jop.2002.73.11.1292Adjunctive local delivery of minocycline microspheres in periodontitis
Williams RC et al. (2001)
DOI: 10.1002/JPER.18-0534Organisms Studied with This Therapy
Related Therapies
Educational use only. This page provides general information and does not recommend this therapy over others or provide medical advice. Always consult a licensed dental or medical professional for diagnosis and treatment decisions.